Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches

Title:Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches

Volume: 23 Issue: 13

Author(s): Eric L. Kaijzel*, Ermond R. van Beek, Marieke A. Stammes, Ivo Que, Alan B. Chan, Clemens W.G.M. Lowik and Luis J. Cruz

Affiliation:

• Translational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden,Netherlands

Keywords: Traumatic brain injury, molecular imaging, nanoparticles, mouse model, probes.

Abstract: Background: Traumatic brain injury (TBI) is the result of an external physical force to the head that harms the brain. TBI is a major public health problem worldwide and mainly results from falls, vehicle accidents and violence.

Clinical problem: The management of TBI, causing a wide spectrum of possible health outcomes, has barely changed over the years as encouraging outcomes from many pre-clinical therapeutic and pharmacological studies have only rarely been translated to the clinical situation.

New management options: In the last decades management of TBI is rapidly advancing and new innovative imaging modalities with sophisticated treatment options by using nanomedicine based drug delivery systems are under investigation. Nano formulations such as PLGA, exosomes and liposomes have the advantage of a targeted and controlled delivery of their cargo, such as diagnostic probes and/or therapeutic drugs.

Summary: Here we provide an overview of new promising pre-clinical developments in TBI management that may find their way to the clinic in the near future. Nanotechnology and nanomedicine in TBI intervention may establish new platforms for targeted drug delivery to the traumatized brain to improve the quality of life and survival of TBI patients.

Cite this article as:

Kaijzel L. Eric*, van Beek R. Ermond, Stammes A. Marieke, Que Ivo, Chan B. Alan, Lowik W.G.M. Clemens and Cruz J. Luis, Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches, Current Pharmaceutical Design 2017; 23(13) . https://dx.doi.org/10.2174/1381612823666170116141116

DOI https://dx.doi.org/10.2174/1381612823666170116141116	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286